D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 19,163 292 World Ranking 13508 National Ranking 7010

Research.com Recognitions

Awards & Achievements

2009 - Member of the National Academy of Medicine (NAM)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Surgery

His scientific interests lie mostly in Fibrodysplasia ossificans progressiva, Heterotopic ossification, Pathology, ACVR1 and Ossification. His Fibrodysplasia ossificans progressiva study incorporates themes from Genetic disorder, Disease, Myositis ossificans, Endochondral ossification and Bone morphogenetic protein. Frederick S. Kaplan studied Heterotopic ossification and Penetrance that intersect with Dermatology, Pseudopseudohypoparathyroidism and STX16.

The Pathology study which covers Stem cell that intersects with Aplastic anemia, Bone marrow, Transplantation and Myocyte. His ACVR1 research includes themes of Mutation, Chondrogenesis, Connective tissue and Anatomy. His Ossification study integrates concerns from other disciplines, such as Heart valve, Progressive osseous heteroplasia and Bone remodeling.

His most cited work include:

  • A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva (840 citations)
  • Bone Formation and Inflammation in Cardiac Valves (821 citations)
  • Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† (325 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Fibrodysplasia ossificans progressiva, Heterotopic ossification, ACVR1, Pathology and Bone morphogenetic protein. Frederick S. Kaplan has included themes like Internal medicine, Myositis ossificans, Endochondral ossification and Endocrinology in his Fibrodysplasia ossificans progressiva study. The study incorporates disciplines such as Ossification, Genetic disorder, Disease and Progressive osseous heteroplasia in addition to Heterotopic ossification.

His ACVR1 research is multidisciplinary, relying on both Mutation, BMPR2, BMP signaling pathway and Bioinformatics. His Pathology study combines topics from a wide range of disciplines, such as Progenitor cell, Stem cell and Cartilage. His Bone morphogenetic protein research is multidisciplinary, incorporating elements of Cancer research, Activin receptor, Signal transduction, Cell biology and Bone morphogenetic protein 2.

He most often published in these fields:

  • Fibrodysplasia ossificans progressiva (72.01%)
  • Heterotopic ossification (47.78%)
  • ACVR1 (29.01%)

What were the highlights of his more recent work (between 2013-2021)?

  • Fibrodysplasia ossificans progressiva (72.01%)
  • Heterotopic ossification (47.78%)
  • ACVR1 (29.01%)

In recent papers he was focusing on the following fields of study:

Frederick S. Kaplan spends much of his time researching Fibrodysplasia ossificans progressiva, Heterotopic ossification, ACVR1, Bone morphogenetic protein and Myositis ossificans. His Fibrodysplasia ossificans progressiva research includes elements of Dermatology, Natural history study, Internal medicine, Endochondral ossification and Pediatrics. Frederick S. Kaplan combines subjects such as Ossification and Genetic disorder, Disease, Pathology with his study of Heterotopic ossification.

His work deals with themes such as Mast cell and Progressive osseous heteroplasia, which intersect with Pathology. His study in ACVR1 is interdisciplinary in nature, drawing from both Mutation, Cancer research, Clinical trial and Connective tissue. His biological study spans a wide range of topics, including Progenitor cell, Signal transduction, Stem cell, Cell biology and Activin receptor.

Between 2013 and 2021, his most popular works were:

  • Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. (90 citations)
  • The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment. (86 citations)
  • Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. (75 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bone Formation and Inflammation in Cardiac Valves

Emile R. Mohler;Francis Gannon;Carol Reynolds;Robert Zimmerman.
Circulation (2001)

1333 Citations

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

Eileen M Shore;Meiqi Xu;George J Feldman;David A Fenstermacher.
Nature Genetics (2006)

1153 Citations

Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans Progressiva

Adam B. Shafritz;Eileen M. Shore;Francis H. Gannon;Michael A. Zasloff.
The New England Journal of Medicine (1996)

488 Citations

Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*†

Kevin B. Freedman;Frederick S. Kaplan;Warren B. Bilker;Brian L. Strom.
Journal of Bone and Joint Surgery, American Volume (2000)

480 Citations

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.

Frederick S. Kaplan;Meiqi Xu;Petra Seemann;J. Michael Connor.
Human Mutation (2009)

418 Citations

The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

Randolph B. Cohen;Gregory V. Hahn;Jeffrey A. Tabas;Jeannie Peeper.
Journal of Bone and Joint Surgery, American Volume (1993)

403 Citations

Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis

Vitali Y. Lounev;Rageshree Ramachandran;Michael N. Wosczyna;Masakazu Yamamoto.
Journal of Bone and Joint Surgery, American Volume (2009)

360 Citations

Fibrodysplasia ossificans progressiva

Frederick S. Kaplan;Martine Le Merrer;David L. Glaser;Robert J. Pignolo.
Best Practice & Research: Clinical Rheumatology (2008)

350 Citations

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

Eileen M. Shore;Jaimo Ahn;Suzanne Jan de Beur;Ming Li;Ming Li.
The New England Journal of Medicine (2002)

300 Citations

The Histopathology of Fibrodysplasia Ossificans Progressiva. An Endochondral Process.

Frederick S. Kaplan;Jeffrey A. Tabas;Francis H. Gannon;Gerald Finkel.
Journal of Bone and Joint Surgery, American Volume (1993)

295 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Frederick S. Kaplan

Yuji Mishina

Yuji Mishina

University of Michigan–Ann Arbor

Publications: 42

Petra Knaus

Petra Knaus

Freie Universität Berlin

Publications: 29

Simon M. Cool

Simon M. Cool

Agency for Science, Technology and Research

Publications: 26

Harald Jüppner

Harald Jüppner

Harvard University

Publications: 25

Alex N. Bullock

Alex N. Bullock

University of Oxford

Publications: 24

Aris N. Economides

Aris N. Economides

Regeneron (United States)

Publications: 24

Peter ten Dijke

Peter ten Dijke

Leiden University Medical Center

Publications: 23

Michael P. Whyte

Michael P. Whyte

Washington University in St. Louis

Publications: 21

Victor Nurcombe

Victor Nurcombe

Agency for Science, Technology and Research

Publications: 21

Linda L. Demer

Linda L. Demer

University of California, Los Angeles

Publications: 21

Alan R. Davis

Alan R. Davis

Baylor College of Medicine

Publications: 20

Jeffrey M. Gimble

Jeffrey M. Gimble

Tulane University

Publications: 18

Hanjoong Jo

Hanjoong Jo

Georgia Institute of Technology

Publications: 18

Roberto Ravazzolo

Roberto Ravazzolo

University of Genoa

Publications: 18

Sharmila Majumdar

Sharmila Majumdar

University of California, San Francisco

Publications: 17

Elena Aikawa

Elena Aikawa

Brigham and Women's Hospital

Publications: 17

Trending Scientists

Ron Alterovitz

Ron Alterovitz

University of North Carolina at Chapel Hill

Dmitri Krioukov

Dmitri Krioukov

Northeastern University

Gennaro Pescitelli

Gennaro Pescitelli

University of Pisa

Erico M.M. Flores

Erico M.M. Flores

Universidade Federal de Santa Maria

Nack J. Kim

Nack J. Kim

Pohang University of Science and Technology

Christopher E. Mason

Christopher E. Mason

Cornell University

Elizabeth T. Borer

Elizabeth T. Borer

University of Minnesota

Ferran Garcia-Pichel

Ferran Garcia-Pichel

Arizona State University

Tatiana V. Petrova

Tatiana V. Petrova

University of Lausanne

Timothy Y. James

Timothy Y. James

University of Michigan–Ann Arbor

Matthias Demuzere

Matthias Demuzere

Ruhr University Bochum

R. Glenn Northcutt

R. Glenn Northcutt

University of California, San Diego

John A. Fairbank

John A. Fairbank

Duke University

Anthony J. Swerdlow

Anthony J. Swerdlow

Institute of Cancer Research

Robert G. Bristow

Robert G. Bristow

University of Manchester

John W. Creswell

John W. Creswell

University of Michigan–Ann Arbor

Something went wrong. Please try again later.